Figure 2
From: Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
Change in ejection fraction pre-/post-treatment with carfilzomib (*post-treatment refers to ejection fraction assessment following four cycles of treatment with carfizomib).
